series-b
Stage
3
Investors
About
Singlera is a biotechnology company specializing in DNA methylation-based molecular diagnostics for early cancer detection, monitoring, and precision oncology, with products covering multiple cancer types and operations in China and the US.
Explore Singlera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.